Andrew Parker
Papers
1
Total Citations
10
H-Index
1
About
Andrew Parker is a leading head and neck surgeon whose research focuses on the surgical management of human papillomavirus (HPV)-associated oropharyngeal squamous cell carcinoma (OPSCC). His major contribution lies in advancing the evidence base for transoral robotic surgery (TORS) as a primary treatment modality for this disease. In his landmark 2024 study, Parker and his team conducted a comprehensive 10-year retrospective cohort review of oncological outcomes following TORS for HPV-positive OPSCC in an Australian single-centre setting. This work, already garnering 10 citations, provides critical real-world data on survival, recurrence, and functional outcomes, helping to solidify TORS as a viable, less morbid alternative to chemoradiation. By systematically documenting the long-term efficacy of this robotic approach, Parker has directly informed clinical decision-making for both surgeons and patients. His research is instrumental in shaping modern, de-escalated treatment paradigms for HPV-driven oropharyngeal cancer, offering a compelling path toward improved quality of life without compromising oncological control.
Research Focus
Key Achievements
Top Papers
- 1